Sri Lanka in deal with India’s Reliance to make plasma proteins
ECONOMYNEXT – Sri Lanka will give surplus blood components to India’s Reliance Life Sciences to make plasma proteins for state hospitals, Health Minister Rajitha Senaratne.
Sri Lanka’s National Blood Transfusion Service uses about 100,000 litres to separate into blood components such as red blood cells and platelets and about 60,000 liters of plasma are used in the country.
But about 40,000 litres of plasma are thrown away each years.
The Cabinet of ministers had approved a plan to give the plasma to India’s Reliance Life Sciences to manufacture plasma proteins for Sri Lanka.
Senaratne said there was a proposal by another company to set up a plasma protein manufacturing plant in Sri Lanka. But until a plant is made in Sri Lanka, surplus plasma will be sold to Reliance Life Sciences.